Solitaire X
Device Stents
PDI 00847536034730
General payments
$307,830
Research payments
$243,048
Through program year 2025, $307,830 in general payments and $243,048 in research payments were reported against Solitaire X (Stents).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $43,820 | 980 |
| 2025 | Research | $91,375 | 33 |
| 2024 | General | $33,542 | 790 |
| 2024 | Research | $72,699 | 36 |
| 2023 | General | $86,922 | 1,173 |
| 2023 | Research | $78,974 | 22 |
| 2022 | General | $143,546 | 1,061 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 48 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 44 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
4,004 general · 91 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.